A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II

A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II

Abstract Background Lertal®, an oral nutraceutical, contains extract of Perilla, quercetin, and Vitamin D3. The current polycentric, randomized, parallel-group, controlled study aimed in the Phase II to evaluate the efficacy and safety of Lertal® in preventing allergic rhinitis (AR) exacerbations in...

Full description

Bibliographic Details
Main Authors: Gianluigi Marseglia, Amelia Licari, Salvatore Leonardi, Maria Papale, Anna Maria Zicari, Laura Schiavi, Giorgio Ciprandi, Italian Study Group on Pediatric Allergic Rhinoconjunctivitis
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Italian Journal of Pediatrics
Subjects:
Allergic rhinoconjunctivitis
Nutraceutical
Perilla frutescens
Quercetin
Vitamin D3
Preventive treatment
Online Access:http://link.springer.com/article/10.1186/s13052-019-0678-y

Internet

http://link.springer.com/article/10.1186/s13052-019-0678-y

Similar Items